Pnemotex®

Pnemotex®

Pneumococcal conjugate vaccine (13-valent, adsorbed).1

Indications

Prevention of pneumococcal infection caused by Streptococcus pneumoniae serotypes 1, 3, 4, 5, 6A, 6B, 7 °F, 9V, 14, 18 °C, 19A, 19 °F, and 23 °F.1.

Age of Use

For children from 2 months of age and adults1.

Vaccination Schedule

  • Initiation at 2–6 months of age, schedules 3+1 or 2+1. Individual immunization: 3 doses at intervals of at least 4 weeks; a booster dose at 11–15 months.
  • Mass immunization: 2 doses at intervals of at least 8 weeks; a booster dose at 12–15 months.
  • Initiation at 7–11 months, schedule 2+1. 2 doses at intervals of at least 4 weeks; a booster dose in the second year of life.
  • Initiation at 12–23 months, schedule 1+1. 2 doses at intervals of at least 8 weeks.
  • Initiation at 2 years of age and older, schedule 1. A single dose.1,2

Manufacturing and Registration

  • Marketing authorization holder: NANOLEK LLC.
  • Registered in the Russian Federation since 2021.
  • Manufactured at the NANOLEK Biomedical Complex since 2021.3

This website uses cookies to provide you with the best user experience. You can read the detailed Cookie Policy.